Embolotherapy Market Size, Share, Trends, Growth 2032

Embolotherapy Industry Perspective

The global embolotherapy market size accrued earnings worth approximately USD 3.97 Billion in 2023 and is predicted to gain revenue of about USD 7.88 Billion by 2032, is set to record a CAGR of nearly 7.92% over the period from 2024 to 2032.

The report covers a forecast and an analysis of the embolotherapy market on a global and regional level. The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes the drivers and restraints of the embolotherapy market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the patient handling device market on a global level.

Request Free Sample

The global embolotherapy market is a fragmented, and competitive landscape. The rising demand for embolotherapy to treat cases of trauma, tumor, and for male infertility, and impotence promises major growth for the market in near future.

Embolotherapy Market: Overview

Embolotherapy today plays a more important role in medicine than ever before. The treatment, endovascular in nature promises to control bleeding, reduction in tumors, and close arteriovenous, among others. The technique is increasingly moving towards minimal-invasive procedures which will likely present major benefits to the rising elderly, and chronic-disease-ridden patient population. The success of the treatment relies on a wide variety of gel foams, angiographic catheters, coils, balloons, and skilled surgeons. The therapy can be permanent or temporary in nature and varies widely depending on the application.

The Embolotherapy Market refers to the global industry centered around the use of embolization techniques for treating various medical conditions. Embolotherapy involves the intentional blocking of blood vessels to stop blood flow to specific areas of the body, commonly used in the treatment of conditions like cancerous tumors, aneurysms, and abnormal blood vessel formations such as arteriovenous malformations (AVMs). This market is driven by factors such as the increasing prevalence of cancer, advancements in minimally invasive surgical techniques, and the growing demand for targeted therapies that offer fewer side effects and quicker recovery times compared to traditional surgery. As healthcare systems continue to adopt more advanced interventional radiology procedures, the embolotherapy market is expected to see substantial growth.

Embolotherapy Market: Growth Factors

The Embolotherapy Market is experiencing significant growth due to several key factors:

• Rising Prevalence of Cancer: As cancer rates continue to increase globally, there is a growing demand for embolotherapy, particularly for treating tumors that are inoperable or require minimally invasive interventions. Embolotherapy, including transarterial chemoembolization (TACE) and radioembolization, is increasingly used to block blood supply to tumors, enhancing the effectiveness of cancer treatment.

• Advancements in Minimally Invasive Procedures: The development of advanced imaging technologies and innovative embolic agents has significantly improved the precision and effectiveness of embolotherapy. These advancements allow for more targeted treatment, reducing damage to surrounding tissues and leading to better patient outcomes. The growing preference for minimally invasive procedures also contributes to the market’s expansion.

• Increasing Incidence of Vascular Diseases: The rising incidence of vascular diseases, such as arteriovenous malformations (AVMs), aneurysms, and varicose veins, is driving the demand for embolotherapy. These conditions often require embolization to prevent complications, such as hemorrhage, making embolotherapy a critical treatment option.

• Growing Adoption in Reproductive Health: Embolotherapy is increasingly used in gynecology, particularly in treating conditions like uterine fibroids and postpartum hemorrhage. The demand for uterine artery embolization (UAE) is rising as it offers a less invasive alternative to traditional surgical methods, preserving fertility and reducing recovery time.

• Aging Population: The global aging population is more susceptible to chronic conditions, including cancer and vascular diseases, which often require embolotherapy. As the elderly population grows, the demand for these minimally invasive treatments is expected to rise, further driving market growth.

• Increasing Healthcare Expenditure: Growing investments in healthcare infrastructure, particularly in emerging economies, are expanding access to advanced medical treatments like embolotherapy. As more healthcare facilities adopt these procedures, the market is likely to see significant growth.

• Favorable Reimbursement Policies: In many regions, favorable reimbursement policies for minimally invasive procedures, including embolotherapy, are encouraging their adoption. These policies reduce the financial burden on patients, making these advanced treatments more accessible.

Overall, the embolotherapy market is poised for robust growth as advancements in technology, rising healthcare needs, and an increasing focus on minimally invasive treatments drive demand.

Embolotherapy Market: Key Trends

According to the latest reports by the Centers for Disease Control and Prevention (CDC), each year 33,000 people in the US are diagnosed with liver cancer. Among these, over 27,000 patients die from the illness. Additionally, the percentage of people receiving liver cancer has steadily been on the rise in the last decade. Moreover, the percentage of people who survive beyond five years remains extremely low with the percentage hovering between 4 to 26.

On the other hand, strokes also remain a key opportunity for improving the lives of patients for players in the global embolotherapy market. Strokes remain the fifth-leading cause of death in the United States, with 7,95,000 cases incidences reported annually.

Additionally, diseases like uterine fibroid are also witnessing a growing rate of diagnosis, thanks to rising awareness of the disease, and increasingly effective treatment procedures. The disease remains a common occurrence among women. Most women develop the condition between 20-80 years of age, and 35% of women experience the condition before they reach menopause.

The rising occurrences of several chronic diseases including cancer, strokes, and their growing adverse effects on the elderly population will create significant opportunities for growth in the global embolotherapy market in near future.

Embolotherapy Market: Segmentation

The global embolotherapy market report is segmented on the basis of disease, products, procedure, end-users, and region.

Among types of diseases, oncology, aneurysm, and peripheral vascular conditions will be studied.

The product segment of the report will cover guidewires, detachable coils, embolic agents, pushable coils, and microspheres.

By End- Users, the data from clinics, hospitals, academia, and ASC will also be presented in the end-user segment.

Embolotherapy Market: Report Scope

Embolotherapy Market: Regional Analysis

The global embolotherapy market will cover all key regions including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these, the rising investment in healthcare in the US will likely create major opportunities for growth in the North American region. Recent legislation in the US has extended programs like Medicare for all elderly patients above 65 years of age. Among other regions, the Asia Pacific region will likely witness the highest CAGR-driven growth, thanks to rising disposable income, and growing access to healthcare.

Embolotherapy Market: Competitive Space

Some of the leading players in the global market include

• Merit Medical Systems
• Boston Scientific Corporation
• Medtronic plc
• Meril Life Sciences Pvt. Ltd.

 The global embolotherapy market is segmented as follows:

By Product Analysis

• Embolic agents
• Microspheres
• Embolic coils
  • Detachable Coils
  • Pushable Coils
• Liquid Embolic Agents
• Embolic Plug Systems
• Detachable Balloons
• Support Devices
• Microcatheters
• Guidewires

By Disease Indication Analysis

• Cancer
• Liver Cancer
• Kidney Cancer
• Other Cancers
• Peripheral Vascular Diseases
• Neurological Diseases
• Cerebral Aneurysm
• Cerebral Arteriovenous Malformations and Fistulas
• Gastrointestinal Disorders
• Urological and Nephrological Disorders

By Procedure Analysis

• Transcatheter Arterial Embolization
• Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy
• Transarterial Chemoembolization

By End User Analysis

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Other End Users

By Region Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa